French face dilemma over adopting biotech patenting Directive
This article was originally published in Clinica
Executive Summary
France should drop its opposition to the patenting of genes and take steps to adopt the EU biotechnology patenting Directive in its entirety. This is the controversial message contained in a report submitted to the French Industry Ministry on March 11. The report was commissioned by Finance Minister Laurent Fabius and drafted by a working group headed by Noelle Lenoir, a judge at the French Constitutional Council and president of the European Group on Ethics in Science and New Technologies